Fingerprint
Dive into the research topics of 'Three‐Year Safety Results of SAR422459 (EIAV‐ABCA4) Gene Therapy in Patients With ABCA4‐Associated Stargardt Disease: An Open‐Label Dose‐Escalation Phase I/IIa Clinical Trial, Cohorts 1‐5: Results of Gene Therapy in Patients With Stargardt Disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically